The MarketWatch News Department was not involved in the creation of this content.
Feb 20, 2023 (The Expresswire) —
Ketogenic Diet Market | Outlook 2023-2028 | Pre and Post-COVID Research is Covered, Report Information | Newest 118 Pages Report The extent and overview of the various commercial opportunities throughout the ensuing years are shown in the global “Ketogenic Diet Market” research report, together with the optimistic revenue projections. Application (, Patients with Epilepsy, Losing Weight People, Others,), Many companies have established official economic ties with the organization, and individual advisors from all over the world have joined forces with it. Type (, , Ketogenic Milk Powder, Ketogenic Snacks, Ketogenic Supplement,)
The major players covered in the Ketogenic Diet market report are:
● Nestle ● DANONE ● Abbott ● Pruvit Ventures ● Bulletproof 360 ● Ajinomoto ● Love Good Fats ● Ketogenic ● OnKeto ● Zeneca ● Quest Nutrition ● Altas Bar ● Natures Plus ● Perfect Keto ● Solace Nutrition ●
Get a sample copy of the Ketogenic Diet Market report 2023
Short Summery About Ketogenic Diet Market:
The ketogenic diet (KD for short) is a formula diet with a high proportion of fat, a low proportion of carbohydrates, protein and other nutrients. This therapy has been used for the treatment of refractory epilepsy in children for decades in the last century.
The ketogenic diet started by observing that starvation can reduce seizures. Long ago, Hippocrates used starvation therapy to treat epilepsy, and Bible mentioned starvation therapy as a method of epilepsy treatment.
Global Ketogenic Diet key players include Nestle, DANONE, Abbott, Pruvit Ventures, Bulletproof 360, etc. Global top five manufacturers hold a share over 40 Persent.
North America is the largest market, with a share about 70 Persent, followed by Europe and Asia-Pacific, have a share over 25 percent. In terms of product, Ketogenic Supplement is the largest segment, with a share about 40 Persent. And in terms of application, the largest application is Patients with Epilepsy, followed by Losing…